¿Cuáles son la etiología, síntomas y criterios del síndrome de ovario poliquístico?
Realice una investigación sobre el SÍNDROME DE OVARIO POLIQUÍSTICO y, donde incluya los siguientes subtemas: Definición Etiología Signos y síntomas Criterios diagnósticos
Summary
Polycystic ovary syndrome (PCOS) is a chronic, heterogeneous endocrine–metabolic disorder of reproductive‑age women, characterized by ovarian dysfunction (oligo/anovulation) and clinical and/or biochemical hyperandrogenism, with or without polycystic ovary morphology on ultrasound, after excluding other causes.[1][2] Its etiology is multifactorial (genetic susceptibility + environmental factors) with a central role of insulin resistance and hyperinsulinemia that amplify ovarian and adrenal androgen excess.[3][4] Clinically it presents with menstrual irregularities, infertility, hirsutism/acne/androgenic alopecia, frequent overweight/central obesity, and long‑term metabolic and cardiovascular risk.[3][5][2] Diagnosis in adults is based on consensus criteria (especially Rotterdam 2003, endorsed and refined by the 2018/2023 international guidelines): at least 2 of 3 (oligo‑/anovulation, hyperandrogenism, polycystic ovaries on ultrasound) with exclusion of other etiologies.[2][6][1]
Definition
- PCOS is the most common endocrine disorder in women of reproductive age, with a prevalence of about 6–16% depending on population and criteria used.[7][8]
- It is defined as a chronic, heterogeneous syndrome characterized by:
According to the recent international evidence‑based guideline and CMAJ review, PCOS is “a chronic, multisystem disorder with reproductive, metabolic and psychological features” and diagnosis is clinical, supported by labs and imaging.[1]
Etiology and Pathophysiology
PCOS has a multifactorial, polygenic etiology:
Genetic and epigenetic factors
- PCOS is considered a complex multigenic disorder where predisposing and protective genetic variants interact with environmental factors such as diet, lifestyle and ethnicity to generate different PCOS phenotypes.[3]
- Family clustering and twin studies support heritable susceptibility, but no single causative gene has been identified; multiple loci involved in gonadotropin action, insulin signaling and steroidogenesis contribute modest effects (GWAS data, summarized in recent reviews and guidelines).[1]
Insulin resistance and hyperinsulinemia
- Insulin resistance (IR) is the most frequent metabolic alteration in PCOS patients.[3]
- IR and compensatory hyperinsulinemia:
- A recent IR review highlights its association with cardiovascular risk, type 2 diabetes and PCOS, and that management is largely lifestyle‑based with individualized pharmacologic support.[4]
Neuroendocrine and ovarian factors
- Many PCOS patients show elevated LH and increased LH:FSH ratio, reflecting hypothalamic–pituitary dysregulation and enhancing theca‑cell androgen synthesis.[8][2][1]
- Intrinsic ovarian hyperandrogenism (theca‑cell hyperresponsiveness) and, in some phenotypes, adrenal androgen excess further contribute.[2][1]
- Low‑grade chronic inflammation and adipose tissue dysfunction are also frequently described and linked to metabolic risk.[9][3]
Environmental and lifestyle factors
- Obesity (particularly central/visceral), sedentary lifestyle and high‑calorie diets increase insulin resistance and hyperandrogenism, often exacerbating PCOS manifestations.[3][4][10]
- Weight gain in genetically susceptible women can unmask or worsen the phenotype; conversely, modest weight loss improves ovulation and metabolic parameters (shown in multiple RCTs and summarized in guidelines).[1]
Clinical Signs and Symptoms
PCOS expression is heterogeneous; not all patients exhibit all features. Common manifestations include:
Menstrual and reproductive manifestations
- Menstrual irregularities:
- Infertility:
- PCOS accounts for about 75–80% of cases of anovulatory infertility.[2]
- Increased risk of early pregnancy loss, gestational diabetes and hypertensive disorders of pregnancy, especially in obese/insulin‑resistant phenotypes.[2][1]
Hyperandrogenic manifestations
- Hirsutism (Ferriman–Gallwey score elevated) is one of the most common symptoms in clinical series of PCOS women.[11][7]
- Acne and seborrhea.
- Androgenic (female‑pattern) alopecia.[8][1]
- Biochemical hyperandrogenism: elevated total or free testosterone, or other androgens, when measured with accurate methods.[6][1]
Metabolic and cardiovascular features
- Overweight and obesity, frequently with abdominal/central adiposity.[3][10]
- Insulin resistance, impaired glucose tolerance, increased risk of type 2 diabetes and gestational diabetes.[3][4][11]
- Atherogenic dyslipidemia: hypertriglyceridemia, low HDL‑cholesterol.[3]
- Greater cardiovascular risk profile, though the magnitude of long‑term hard event risk remains under study.[3][1]
Other manifestations
- Polycystic ovary morphology on ultrasound:
- Psychological and quality‑of‑life impact:
Diagnostic Criteria
Diagnosis is clinical, supported by labs and imaging, and requires exclusion of other causes (e.g., non‑classic congenital adrenal hyperplasia, androgen‑secreting tumors, Cushing syndrome, thyroid disease, hyperprolactinemia).[6][1]
Three main sets of criteria are used; current international guidelines for adult women recommend Rotterdam criteria (with clarifications) as standard.[6][1]
1. Rotterdam criteria (2003) – most widely used
Diagnosis of PCOS requires 2 of the following 3 features, after excluding other etiologies:[2][6][1]
-
Oligo‑ovulation or anovulation
-
Clinical and/or biochemical hyperandrogenism
-
Polycystic ovaries on ultrasound
Phenotypes (A–D) are defined based on which of the three criteria are present.[6][1]
2. NIH 1990 criteria
- Require both:
- Clinical and/or biochemical hyperandrogenism, and
- Chronic anovulation,
- With exclusion of other causes.
- Ultrasound morphology is not required.[8][6]
- These criteria identify a more “classic” and metabolically severe subset of PCOS patients.[6][1]
3. AE‑PCOS Society criteria (2006)
- Emphasize hyperandrogenism as mandatory.
- Require:
- Clinical and/or biochemical hyperandrogenism, plus
- Ovarian dysfunction (oligo‑anovulation and/or polycystic ovaries),
- After exclusion of related disorders.[6]
Current international guideline approach
Recent international evidence‑based guidelines (2018, updated in reviews through 2024) and the CMAJ 2024 article highlight:[1][6]
- For adults:
- Use Rotterdam (2 of 3) criteria, with updated ultrasound thresholds where available and careful exclusion of mimicking disorders.
- For adolescents:
- Diagnosis is more restrictive; requires both hyperandrogenism and persistent ovulatory dysfunction several years after menarche, and PCOM alone is not diagnostic due to the high frequency of multifollicular ovaries in normal puberty.
- To reduce overdiagnosis, emphasize:
If you specify your educational level (e.g., undergraduate vs. medical student vs. resident), I can adapt this into a more simplified schematic or into exam‑style bullet points.
Fuentes
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11001390/
- https://www.uticvirtual.edu.py/revista.ojs/index.php/revistas/article/view/1083
- https://ojs.southfloridapublishing.com/ojs/index.php/jdev/article/view/5236
- https://www.camjol.info/index.php/RMH/article/view/13824
- https://www.semanticscholar.org/paper/8bb4758a52fb6e30c1eff35de93962ab24deb438
- https://revistas.uis.edu.co/index.php/revistamedicasuis/article/download/11821/11248
- https://rsdjournal.org/index.php/rsd/article/download/45199/36070
- https://linkinghub.elsevier.com/retrieve/pii/S1575092206711664
- https://bjihs.emnuvens.com.br/bjihs/article/download/2953/3133
- https://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/31278
- https://revistacientifica.sudamericana.edu.py/index.php/scientiamericana/article/view/314
- https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/359
- https://www.semanticscholar.org/paper/5dc1c1e723a05512f481e44f95ec2c696fee4b2e
- https://www.semanticscholar.org/paper/d3a8d45e70dfd2ccc1f123a92df79755788e4b48
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4943359/
Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.